Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for EVOTF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 2005. Start Trial.
Date Value
May 31, 2026 90.95%
April 30, 2026 90.95%
March 31, 2026 90.95%
February 28, 2026 88.55%
January 31, 2026 88.55%
December 31, 2025 88.55%
November 30, 2025 88.55%
October 31, 2025 88.55%
September 30, 2025 88.55%
August 31, 2025 88.55%
July 31, 2025 88.55%
June 30, 2025 88.55%
May 31, 2025 88.55%
April 30, 2025 88.55%
March 31, 2025 88.55%
February 28, 2025 88.55%
January 31, 2025 88.55%
December 31, 2024 88.55%
November 30, 2024 88.55%
October 31, 2024 88.55%
September 30, 2024 88.55%
August 31, 2024 88.55%
July 31, 2024 82.80%
June 30, 2024 82.80%
May 31, 2024 81.13%
Date Value
April 30, 2024 80.50%
March 31, 2024 73.51%
February 29, 2024 72.40%
January 31, 2024 69.35%
December 31, 2023 68.04%
November 30, 2023 68.04%
October 31, 2023 68.04%
September 30, 2023 68.04%
August 31, 2023 68.04%
July 31, 2023 68.04%
June 30, 2023 68.04%
May 31, 2023 68.04%
April 30, 2023 68.04%
March 31, 2023 68.04%
February 28, 2023 68.04%
January 31, 2023 68.04%
December 31, 2022 68.04%
November 30, 2022 68.04%
October 31, 2022 67.03%
September 30, 2022 67.03%
August 31, 2022 53.33%
July 31, 2022 53.33%
June 30, 2022 53.33%
May 31, 2022 52.86%
April 30, 2022 49.87%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Lifecore Biomedical, Inc. 89.19%
Codexis, Inc. 97.65%
Quanterix Corp. 96.26%
Sartorius Stedim Biotech SA 63.42%
CureVac NV 98.30%